Drug
Bepotastine besilate clinical trials
Also written Bepreve and TALION®.
- studies test it
- 16
- open now
- 0
- in phase 3
- 6
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 4
- Phase 3
- 6
- Phase 4
- 3
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 3
Bausch & Lomb Incorporated (6) · Tanabe Pharma Corporation (3) · Laboratorios Sophia S.A de C.V. (1) · Laboratorios Poen (1) · Southern California College of Optometry at Marshall B. Ketchum University (1) · Dong-A ST Co., Ltd. (1) · Daewoong Pharmaceutical Co. LTD. (1) · McCabe Vision Center (1)
Often tested with
Tested in the same studies.
Loteprednol Etabonate (1) · DA-5206 (1) · Olopatadine (1)
Studies
Open first, then newest update. How each study uses bepotastine besilate is read from its arms, and is right about nine times in ten.
Testing it · 16
- The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedPhase 3Tanabe Pharma CorporationNCT01861522Written as Bepotastine besilate
- A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedPhase 3Tanabe Pharma CorporationNCT01840605Written as Bepotastine besilate
- A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedPhase 3Tanabe Pharma CorporationNCT01900054Written as Bepotastine besilate
- Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+CompletedPhase 1Laboratorios Sophia S.A de C.V.NCT04693429Written as Bepotastine Besilate
- Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis TreatmentCompletedPhase 4Laboratorios PoenNCT04776096Written as Bepotastine Besilate 1.5% PF
- Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedPhase 2Bausch & Lomb IncorporatedNCT01753739Written as Bepotastine besilate
- Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic RhinitisCompletedPhase 2Bausch & Lomb IncorporatedNCT01277341Written as Bepotastine Besilate Nasal Spray 2% Twice a day
- Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis PatientsCompletedPhase 2Bausch & Lomb IncorporatedNCT01174823Written as bepotastine besilate ophthalmic solution
- Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic ConjunctivitisCompletedPhase 4Southern California College of Optometry at Marshall B. Ketchum UniversityNCT01443442Written as bepotastine besilate, 1.5%
- Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male SubjectsCompletedPhase 1Dong-A ST Co., Ltd.NCT03200496Written as TALION®
- Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT02332044Written as Talion
- Comparing Patient Satisfaction With Pataday or BepreveCompletedNot applicableMcCabe Vision CenterNCT01450176Written as Bepotastine besilate ophthalmic solution 1.5%
- Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal VolunteersCompletedPhase 3Bausch & Lomb IncorporatedNCT00586625Written as Bepreve
- Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic ConjunctivitisCompletedPhase 2/3Bausch & Lomb IncorporatedNCT00424398Written as Bepreve
- Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT00586664Written as Bepreve (bepotastine besilate ophthalmic solution) 1.5%
- The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick TestingCompletedPhase 4North Texas Institute for Clinical TrialsNCT01128556Written as Bepreve
Codes
What other systems call bepotastine besilate · ClinicalTrials.gg INT004934
- MeSH (NLM) C511534bepotastine besilateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6W18MO1QR3BEPOTASTINE BESYLATEConfirmed FDA, NLM, Wikidata
- RxNorm 658552Confirmed FDA, Wikidata
- Wikidata Q27114261bepotastine besilateConfirmed FDA, NLM, Wikidata
- DrugBank DBSALT000017One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C511534 | bepotastine besilate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6W18MO1QR3 | BEPOTASTINE BESYLATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 658552 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27114261 | bepotastine besilate | Confirmed FDA, NLM, Wikidata |
| DrugBank | DBSALT000017 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.